Evidence Generation Intern

Genmab; Princeton (NJ); Hybrid; USD 28,000 - 36,000; Part time

Benefits offered by this job

Hybrid schedule

Job summary

Genmab in Princeton, NJ is seeking an Evidence Generation Intern to support drug development by delivering on Evidence Generation programs within Medical Affairs.

This internship will involve supporting Investigator-Driven and Managed Access programs, coordinating governance meetings, timelines and milestones, and collaborating with cross-functional teams to drive program success over a 10-week hybrid schedule with three days in the office and two remote days per week.

Qualifications

• Enrolled in a Bachelor's or Advanced degree in a scientific discipline.
• Strong analytical and problem‑solving abilities.
• Excellent written and verbal communication skills.
• Ability to work independently and as part of a collaborative team.
• Maintains attention to detail and quality in all deliverables while managing multiple tasks.

Responsibilities

• Participate in successful implementation of Investigator-Driven and Managed Access Programs
• Support different governance meetings to drive and deliver on Evidence Generation Programs
• Support operational timelines and key deliverables
• Facilitate management of study or program proposal lifecycle from submission to study closure
• Support successful management of all aspects of investigator-driven programs within designated program budgets and timelines
• Collaborate with cross‑functional teams and partners to manage, adjust, and revise project milestones as necessary
• Collaborate with EvGen team to generate regular metrics and reports of program activities
• Participate in mentorship meetings and contribute to team discussions on process improvements and best practices.

Skills

Analytical skills

Written and verbal communication

Team collaboration

Attention to detail

Education

Bachelor's or Advanced degree in a scientific discipline

Job description

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

Job Title

Evidence Generation Intern

Why Genmab

At Genmab, interns don’t just learn about the work - they help move it forward. Our internship program provides meaningful, hands‑on experience through real projects that directly support our teams, business priorities, and mission to transform the lives of people with cancer and other serious diseases.

From day one, interns are welcomed as part of the team and given opportunities to contribute, collaborate, and make an impact. Along the way, you’ll learn from talented colleagues and senior leaders, build new skills, expand your professional network, and gain exposure to the innovative work happening across Genmab.

We’re always looking for smart, curious, purpose‑led people who are ready to bring fresh perspectives and bold ideas. Explore our website to learn more about Genmab and how you could play a role in our bold, extra[not]ordinary® future.

Job Overview

The Evidence Generation Intern supports Genmab’s drug development efforts by working directly with the team to deliver on Evidence Generation programs.

This position will be responsible for supporting operational aspects of Investigator-Driven Programs: Investigator‑Sponsored trials (ISTs), Collaborative Research Trials (CRTs), Managed Access Programs (Individual and Protocol) and other Evidence Generation initiatives within Medical Affairs.

What You’ll Do

• Participate in successful implementation of Investigator-Driven and Managed Access Programs
• Support different governance meetings to drive and deliver on Evidence Generation Programs
• Support operational timelines and key deliverables
• Facilitate management of study or program proposal lifecycle from submission to study closure
• Support successful management of all aspects of investigator-driven programs within designated program budgets and timelines
• Collaborate with cross‑functional teams and partners to manage, adjust, and revise project milestones as necessary
• Collaborate with EvGen team to generate regular metrics and reports of program activities
• Participate in mentorship meetings and contribute to team discussions on process improvements and best practices.

Required Qualifications, Capabilities and Skills

• Enrolled in a Bachelor's or Advanced degree in a scientific discipline.
• Strong analytical and problem‑solving abilities.
• Excellent written and verbal communication skills.
• Ability to work independently and as part of a collaborative team.
• Maintains attention to detail and quality in all deliverables while managing multiple tasks.

Preferred Qualifications, Capabilities and Skills

• Basic understanding of clinical research is preferred.
• Demonstrates initiative, a proactive attitude, and eagerness to learn in a fast‑paced environment.
• Effectively communicates and collaborates with team members, mentors, and stakeholders.

General Intern Information – Date/Location/Schedule

Internships will take place over 10 weeks from June – August 2027. This role will be based in Princeton, NJ and operate on a required hybrid schedule – 3 days in the office and 2 days remote per week. This role is not eligible for work visa sponsorship at the time of the application or in the future.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard‑working, innovative and collaborative team has invented next‑generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T‑cell engagers, antibody‑drug conjugates, next‑generation immune checkpoint modulators and effector function‑enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock‑Your‑Socks‑Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).